[1]旷文华.依那普利叶酸片治疗脑梗死伴H型高血压患者的效果[J].医学信息,2021,34(13):166-169.[doi:10.3969/j.issn.1006-1959.2021.13.046]
　KUANG Wen-hua.Effect of Enalapril Folic Acid Tablets on Patients with Cerebral Infarction and H-type Hypertension[J].Medical Information,2021,34(13):166-169.[doi:10.3969/j.issn.1006-1959.2021.13.046]
点击复制

依那普利叶酸片治疗脑梗死伴H型高血压患者的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年13期
页码:
166-169
栏目:
药物与临床
出版日期:
2021-07-01

文章信息/Info

Title:
Effect of Enalapril Folic Acid Tablets on Patients with Cerebral Infarction and H-type Hypertension
文章编号:
1006-1959（2021）13-0166-04
作者:
旷文华
（广州市白云区妇幼保健院内三科，广东 广州 510410）
Author(s):
KUANG Wen-hua
(Subject Three,Department of Internal Medicine,Maternal and Child Health Hospital of Baiyun District, Guangzhou 510410,Guangdong,China)
关键词:
脑梗死伴H型高血压; 马来酸依那普利叶酸片; 神经功能
Keywords:
Cerebral infarction with H-type hypertension; Enalapril maleate folic acid tablets;  Nerve function
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2021.13.046
文献标志码:
A
摘要:
目的 探讨依那普利叶酸片治疗急性脑梗死合并H型高血压患者的疗效及对患者血浆同型半胱氨酸（Hcy）、NIHSS、ADL、mRS水平的影响。方法 选取2018年6月~2019年12月广州市白云区妇幼保健院收治的伴有H型高血压的急性脑梗死患者127例作为研究对象，按照随机数字表法分为常规治疗组（32例）、叶酸片组（33例）、依那普利组（31例）、依那普利叶酸片组（31例）。常规治疗组予以阿司匹林肠溶片联合苯磺酸氨氯地平片治疗，在常规治疗组基础上，依那普利组予以马来酸依那普利片治疗，叶酸片组予以叶酸片治疗，依那普利叶酸组予以马来酸依那普利叶酸片治疗，比较四组治疗前后神经功能缺损程度、日常生活能力、神经功能恢复情况及Hcy水平。结果 治疗后2周、1个月、3个月，依那普利叶酸组NIHSS评分、mRS评分均低于叶酸片组、依那普利组、常规治疗组，ADL评分均高于叶酸片组、依那普利组、常规治疗组，差异有统计学意义（P＜0.05）；而叶酸片组、依那普利组、常规治疗组NIHSS评分、ADL评分、mRS评分比较，差异无统计学意义（P＞0.05）。依那普利叶酸组Hcy水平低于叶酸片组、依那普利组、常规治疗组，差异有统计学意义（P＜0.05）。结论 依那普利叶酸片可有效降低急性脑梗死合并H型高血压患者血浆Hcy水平，改善其临床症状及预后，提高日常生活能力。
Abstract:
Objective To investigate the efficacy of enalapril folic acid tablets in the treatment of acute cerebral infarction patients with H-type hypertension and its effect on plasma homocysteine(Hcy), NIHSS, ADL and mRS levels.Methods 127 patients with acute cerebral infarction with H-type hypertension who were admitted to the Guangzhou Baiyun District Maternity and Child Health Hospital from June 2018 to December 2019 were selected as the research objects.According to the random number table, they were divided into conventional treatment group (32 cases), folic acid tablets group (33 cases), enalapril group (31 cases), and enalapril folic acid tablets group (31 cases).The conventional treatment group was treated with aspirin enteric-coated tablets combined with amlodipine besylate tablets. On the basis of the conventional treatment group, the enalapril group was treated with enalapril maleate tablets, and the folic acid group was treated with folic acid tablets. The nazepril folic acid group was treated with enalapril maleate folic acid tablets,the degree of neurological deficit, ability of daily living, recovery of neurological function and Hcy level were compared among the four groups before and after treatment.Results Two weeks, one month, and three months after treatment, the NIHSS score and mRS score of the enalapril folic acid group were lower than those of the folic acid tablet group, enalapril group, and conventional treatment group.The ADL scores were all higher than the folic acid tablets group, enalapril group, and conventional treatment group,the difference was statistically significant (P<0.05);There was no statistically significant difference in the NIHSS score, ADL score, and mRS score of the folic acid tablet group, enalapril group, and conventional treatment group (P>0.05).The Hcy level of the enalapril folic acid group was lower than that of the folic acid tablet group, enalapril group, and conventional treatment group,the difference was statistically significant (P<0.05).Conclusion Enalapril folic acid tablets can effectively reduce the plasma Hcy level in patients with acute cerebral infarction and H-type hypertension, improve their clinical symptoms and prognosis, and improve the ability of daily living.

参考文献/References:

[1]宋良,付胜奇,杜家琇,等.短暂性症状伴梗死的相关危险因素分析及再发缺血性脑卒中的风险预测[J].中国实用神经疾病杂志,2020,23(8):655-660. [2]李琼,张莉莉,李楠楠.马来酸依那普利联合叶酸片对老年高同型半胱氨酸血症并发脑梗死患者血管内皮功能的影响[J].中国老年学杂志,2017,8(37):3750-3751. [3]康聚贤,张培,尹少华,等.钙离子拮抗剂联合叶酸治疗伴H型高血压急性脑梗死的临床分析[J].系统医学,2016,l(9):33-37． [4]黄坤.H型高血压与进展性卒中的相关性研究[J].中外医疗,2015,34(36):49-55. [5]康聚贤,张培,尹少华,等.不同降压药联合叶酸对伴H型高血压急性脑梗死的疗效研究[J].中国卫生标准管理,2016,7(11):121-122． [6]王赛华,赵志宏,罗俊,等.H型高血压病人合并急性脑梗死与颈动脉粥样硬化的相关性[J].中西医结合心脑血管病杂志,2016,14(17):1984-1986. [7]Sydorskyy Y,Dilworth DJ,Yi EC,et al.Intersection of the Kap123p-mediated nuclear import and ribos ome export pathways[J].Mol Cell Biol,2003,23(6):2042-2054. [8]吕雅丽,王清.高同型半胱氨酸血症对急性缺血性脑卒中预后的影响[J].陕西医学杂志,2007,36(4):457-459. [9]刘新哲.依那普利叶酸片辅治H型高血压致急性脑梗死患者及对NIHSS评分影响分析[J].数理医药学杂志,2020,33(6):919-920. [10]张艺洁.叶酸联合血管紧张素转化酶抑制剂对H型高血压患者血管紧张素转化酶活性的影响及相关因素分析[D]. 昆明医科大学,2017. [11]马晶晶,彭莉,任晖,等.补充硒和叶酸对冠心病射血分数降低心力衰竭伴高同型半胱氨酸血症病人BNP、Hcy、心功能的影响[J].中西医结合心脑血管病杂志,2019,17(17):2642-2646. [12]Arendse LB,Danser AHJ,Poglitsch M,et al.Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure[J].Pharmacol Rev,2019,71(4):539-570. [13]鲍金圭,檀润先,梁朝莹,等.多项实验室指标与急性脑梗死的关系[J].国际检验医学杂志,2016,37(21):2993-2995． [14]张医虎,寿松涛,刘艳存,等.依那普利叶酸片治疗H型高血压效果的Meta分析[J].山东医药,2015,55(17):54-56. [15]张燕,李永梅,范永新,等.依那普利叶酸片辅治H型高血压致急性脑梗死患者的临床效果观察[J].临床合理用药杂志,2016,9(7):50-52. [16]孙贵祥,孙培丽,张芾,等.依那普利叶酸片辅治H型高血压致急性脑梗死患者的临床效果分析[J].中国现代医生,2017,55(23):36-38.

相似文献/References:

[1]谭碧峰,黄友良,凌 莎,等.基于有序Logistic回归模型的H型高血压疗效影响因素研究[J].医学信息,2022,35(05):69.[doi:10.3969/j.issn.1006-1959.2022.05.017]
　TAN Bi-feng,HUANG You-liang,LING Sha,et al.Analysis of Influencing Factors on the Efficacy of H-type hypertension Based on Ordinal Logistic Regression Model[J].Medical Information,2022,35(13):69.[doi:10.3969/j.issn.1006-1959.2022.05.017]

更新日期/Last Update: 1900-01-01